COMMUNIQUÉS West-GlobeNewswire

DBV Technologies publie son « Form 10-K » américain et son Document d’Enregistrement Universel 2024
11/04/2025
Châtillon, France, le 11 avril 2025 DBV Technologies publie son « Form 10-K » américain et son Document d’Enregistrement Universel 2024 DBV Technologies (Euronext : DBV – ISIN : FR0010417345 - Nasdaq : DBVT), une [...]
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/04/2025
CAMBRIDGE, Mass., April 11, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with [...]
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
11/04/2025
BEDFORD, Mass., April 11, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced that it has granted [...]
Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock
11/04/2025
NEW YORK, April 11, 2025 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") announced today that, pursuant to a securities purchase agreement (the “Purchase Agreement”) with Blue [...]
Polyrizon Receives Nasdaq Notification Regarding Minimum Bid Requirements
11/04/2025
Raanana, Israel, April 11, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, [...]
Organogenesis Supports CMS’ Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness
11/04/2025
Organogenesis recommends CMS also implement an integrated coverage and payment policy CANTON, Mass., April 11, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company [...]
4DMT Announces New Employment Inducement Grants
11/04/2025
EMERYVILLE, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with [...]
argenx Announces Annual General Meeting of Shareholders on May 27, 2025
11/04/2025
April 11, 2025, 10:01 PM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today [...]
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/04/2025
SAN FRANCISCO, April 11, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein [...]
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/04/2025
WOBURN, Mass., April 11, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the grant of [...]
WORK Medical Technology Group LTD Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
11/04/2025
Hangzhou, China, April 11, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices, through its subsidiary, Work (Hangzhou) Medical [...]
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
11/04/2025
PALO ALTO, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases, today announced that [...]
Founder Mina Sooch Issues Open Letter to Opus Genetics Stockholders Following Withdrawal of the Restore Value Slate Amid Dilutive Financing and Governance Concerns
11/04/2025
Board Timed Highly Dilutive Financing to Close on the Record Date for the Annual Meeting, Tilting the Vote and Forcing the Withdrawal of the Restore Value Slate Second Major Transaction in Six Months Undertaken Without [...]
Winstrol Steroid 2025 - Best Legal Winstrol Pills Before And After, Results, Benefits, Side Effects, Dosage – By CrazyBulk
11/04/2025
NEW YORK, April 11, 2025 (GLOBE NEWSWIRE) -- Winsol is equipped with ingredients, such as the wild yam root, to support optimal testosterone synthesis. While it does not directly boost testosterone, the product may help [...]
Trenbolone Steroid Cycle for Bodybuilding: Trenbolone Benefits for Muscle Growth - Where to Buy Tren Pills Online from CrazyBulk
11/04/2025
NEW YORK, April 11, 2025 (GLOBE NEWSWIRE) -- When it comes to achieving incredible muscle growth results in bodybuilding, few steroids are as powerful and revered as Trenbolone. Known for its unmatched ability to [...]
TestoPrime Reviews: Best Testosterone Booster Supplement For Men Over 40 & 50 – Is TestoPrime Tablets Safe?
11/04/2025
GLASGOW, United Kingdom, April 11, 2025 (GLOBE NEWSWIRE) -- There are relatively few testosterone boosters with natural substances that have been clinically shown to increase testosterone levels without producing side [...]
Dianabol for Bulking in 2025: Buy Safe D-Bal Pills Online for Muscle Growth and Strength Gains from Crazy Bulk
11/04/2025
NEW YORK, April 11, 2025 (GLOBE NEWSWIRE) -- Dianabol steroids have been a cornerstone for bodybuilders aiming to achieve massive muscle gains and unparalleled strength during bulking cycles. In 2025, legal Dianabol [...]
Dianabol Steroid: Dianabol Benefits, Dianabol Side Effects, Results & Buy Dianabol (Dbol) Pills Alternatives From D-Bal Crazybulk
11/04/2025
NEW YORK, April 11, 2025 (GLOBE NEWSWIRE) -- “Like you, we’re crazy about bodybuilding. Nothing means more to us than beating our 1 rep max, piling on pounds of muscle and looking better than we’ve ever looked before. D [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of March 31, 2025
11/04/2025
Disclosure of Share Capital and Voting Rights Outstanding as of March 31, 2025 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]

Pages